Report Company Directory
- Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026 by GlobeNewsWire
- US Pharmaceuticals & Biotechnology "M&A Should Be a Continued Theme in..." by UBS AG
- Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor by GlobeNewsWire
- Wedbush Morning Call - Jan 28 2026 6:53AM by Wedbush
- US Thematic Research - Private Healthcare Outlook Series "Therapeutics: We..." by UBS AG
- Daily Recap: WBD/NFLX,LKQ,SKYT/IONQ, LE,HOLX,GME,BOBS,ONL,CCA,PUM,CRM,CSGP,APTV by Wedbush
- Wedbush Morning Call - Jan 27 2026 7:04AM by Wedbush
- Daily Recap: RVMD/MRK, SKYT/IONQ, USAR, INMD, ETN, RDWR, JHG, LDOS, AAUC, IRBTQ by Wedbush
- You Can Never Kill the Revolution by Wedbush
- Wedbush Morning Call - Jan 20 2026 7:01AM by Wedbush